Abbott Labs's most recent trend suggests a bullish bias. One trading opportunity on Abbott Labs is a Bull Put Spread using a strike $105.00 short put and a strike $97.50 long put offers a potential 7.45% return on risk over the next 30 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $105.00 by expiration. The full premium credit of $0.52 would be kept by the premium seller. The risk of $6.98 would be incurred if the stock dropped below the $97.50 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Abbott Labs is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Abbott Labs is bullish.
The RSI indicator is at 60.73 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Abbott Labs
CORRECTED-U.S. government to send out over 7 million Abbott BinaxNOW tests this week
Mon, 16 Nov 2020 16:56:02 +0000
The U.S. government will send over 7 million of Abbott Laboratories' BinaxNOW rapid antigen tests for COVID-19 to states, hospice providers, and for other uses this week, a top administration official said at a press briefing on Monday. In addition to the more than 7 million tests being distributed, the agency will have 820,000 tests remaining for any unanticipated emergency testing demands that could arise as COVID-19 cases spike around the country. The U.S. Department of Health and Human Services will push the U.S. Food and Drug Administration to review COVID-19 tests developed by universities, said Admiral Brett Giroir, assistant secretary for health at the U.S. Department of Health and Human Services.
Abbott Named Industry Sustainability Leader for the Eighth Year in a Row on the Dow Jones Sustainability Index (DJSI)
Mon, 16 Nov 2020 15:20:00 +0000
For the eighth consecutive year, Abbott (NYSE: ABT) has been named the industry leader in sustainability by the Dow Jones Sustainability Index (DJSI), one of the most prestigious global benchmarks for corporate sustainability. As the Global Industry Leader in the Health Care Equipment & Supplies sector, the company earned top scores for governance/economic and social performance. This is the 16th consecutive year that Abbott has been recognized as a sustainability leader through its inclusion on the DJSI, including both the Dow Jones Sustainability World Index and North America Index.
Top 10 Stocks Billionaire Ray Dalio Just Bought
Mon, 16 Nov 2020 02:51:58 +0000
In this article we present the list of Top 10 Stocks Billionaire Ray Dalio Just Bought. Click to skip ahead and see the Top 5 Stocks Billionaire Ray Dalio Just Bought. Ray Dalio is the billionaire Founder, Co-Chairman and Co-Chief Investment Officer of Bridgewater Associates, the largest hedge fund in the world with over $140 billion […]
Forget Snowflake! Buy This Ultra-High-Growth Stock
Sat, 14 Nov 2020 14:08:00 +0000
Investors have understandably bid up shares of companies that deliver software as a service this year as those companies continue to benefit from a work-from-home world. For an example, we need only to look at the initial public offering of cloud-based data and analytics company Snowflake (NYSE: SNOW) — its shares more than doubled on its first day of trading in September. For instance, of the 463 million people with diabetes worldwide, only 25% are receiving care for the disease.
Abbott Labs, Intuitive Surgical Headline 5 Top Stocks Near Buy Points
Sat, 14 Nov 2020 13:00:18 +0000
Intuitive Surgical and Abbott Labs are among 5 top stocks near buy points as the market moves on coronavirus hopes and fears.
Also on Market Tamer…
Follow Us on Facebook